Conditions: Schizophrenia
Keywords: Schizophrenia Latuda Lurasidone
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 478
Healthy volunteers: no

Brief summary:
Lurasidone HCl is a compound developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is more efficacious than placebo. The study will also evaluate the safety and tolerability of lurasidone as compared to placebo.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: Lurasidone intervention 2: Olanzapine intervention 3: Placebo comparator intervention 4: Lurasidone 40 mg tablets
Intervention descriptions: intervention 1: 120mg/day intervention 2: 15mg/day intervention 3: Placebor Comparator intervention 4: Lurasidone 40 mg tablets

Protocol document: